MedKoo Cat#: 414729 | Name: Vibozilimod
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Vibozilimod, also known as SCD-044, is an immunomodulator and SIPR1 agonist with applications in treating moderate to severe psoriasis.

Chemical Structure

Vibozilimod
Vibozilimod
CAS#1403232-33-6

Theoretical Analysis

MedKoo Cat#: 414729

Name: Vibozilimod

CAS#: 1403232-33-6

Chemical Formula: C29H36ClN3O5

Exact Mass: 541.2343

Molecular Weight: 542.07

Elemental Analysis: C, 64.26; H, 6.69; Cl, 6.54; N, 7.75; O, 14.76

Price and Availability

Size Price Availability Quantity
25mg USD 1,950.00 2 Weeks
50mg USD 2,950.00 2 Weeks
100mg USD 4,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Vibozilimod; SCD-044; SCD 044; SCD044;
IUPAC/Chemical Name
1-[(4-{5-[3-chloro-4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl}phenyl)methyl]-4-[(2-methoxyethoxy)methyl]piperidine-4-carboxylic acid
InChi Key
LIVCREVOSRJFDS-UHFFFAOYSA-N
InChi Code
InChI=1S/C29H36ClN3O5/c1-20(2)16-23-8-9-24(17-25(23)30)27-31-26(32-38-27)22-6-4-21(5-7-22)18-33-12-10-29(11-13-33,28(34)35)19-37-15-14-36-3/h4-9,17,20H,10-16,18-19H2,1-3H3,(H,34,35)
SMILES Code
O=C(C1(COCCOC)CCN(CC2=CC=C(C3=NOC(C4=CC=C(CC(C)C)C(Cl)=C4)=N3)C=C2)CC1)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 542.07 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Drakos, A., & Vender, R. (2022). A review of the clinical trial landscape in psoriasis: an update for clinicians. Dermatology and Therapy, 12(12), 2715-2730. 2: Tomar, Y., Gorantla, S., & Singhvi, G. (2023). Insight into the pivotal role of signaling pathways in psoriasis pathogenesis, potential therapeutic molecules and drug delivery approaches. Drug discovery today, 28(2), 103465.